Identification of eIF6 as a prognostic factor that drives tumor progression and predicts arsenic trioxide efficacy in lung adenocarcinoma
暂无分享,去创建一个
[1] Song Gao,et al. BZW1 Facilitates Glycolysis and Promotes Tumor Growth in Pancreatic Ductal Adenocarcinoma Through Potentiating eIF2α Phosphorylation. , 2021, Gastroenterology.
[2] Linzhi Han,et al. Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma , 2021, Cancer medicine.
[3] Qifeng Yang,et al. Circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating Wnt/beta-catenin pathway. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.
[4] S. Biffo,et al. Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma , 2021, Nature Communications.
[5] Yung-An Tsou,et al. Additive Antiproliferative and Antiangiogenic Effects of Metformin and Pemetrexed in a Non-Small-Cell Lung Cancer Xenograft Model , 2021, Frontiers in Cell and Developmental Biology.
[6] F. Aqil,et al. Exosome-mediated delivery of RNA and DNA for gene therapy. , 2021, Cancer letters.
[7] H. Ji,et al. Nanog maintains stemness of Lkb1‐deficient lung adenocarcinoma and prevents gastric differentiation , 2021, EMBO molecular medicine.
[8] B. Xiao,et al. tRNA-derived fragments: Mechanisms underlying their regulation of gene expression and potential applications as therapeutic targets in cancers and virus infections , 2021, Theranostics.
[9] Yanjing Li,et al. Systematic Analysis of Expression Profiles and Prognostic Significance for FAM83 Family in Non-small-Cell Lung Cancer , 2020, Frontiers in Molecular Biosciences.
[10] C. Rudin,et al. Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer , 2020, Cell reports.
[11] Tianrui Xu,et al. Eukaryotic translation initiation factors as promising targets in cancer therapy , 2020, Cell Communication and Signaling.
[12] M. Sos,et al. The next tier of EGFR resistance mutations in lung cancer , 2020, Oncogene.
[13] Shiming Yang,et al. Translation of noncoding RNAs and cancer. , 2020, Cancer letters.
[14] Hong Shen,et al. eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway , 2020, Journal of Translational Medicine.
[15] E. Feuer,et al. The Effect of Advances in Lung-Cancer Treatment on Population Mortality. , 2020, The New England journal of medicine.
[16] Junming Xu,et al. Integrative Proteomic Characterization of Human Lung Adenocarcinoma , 2020, Cell.
[17] W. Weichert,et al. New Pancreatic Cancer Biomarkers eIF1, eIF2D, eIF3C and eIF6 Play a Major Role in Translational Control in Ductal Adenocarcinoma , 2020, AntiCancer Research.
[18] W. Xue,et al. Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma , 2020, Signal Transduction and Targeted Therapy.
[19] Yiyan Lei,et al. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling , 2020, Theranostics.
[20] Kwok-Kin Wong,et al. Notch inhibition overcomes resistance to Tyrosine Kinase Inhibitors in EGFR-driven lung adenocarcinoma. , 2019, The Journal of clinical investigation.
[21] G. Freeman,et al. In vivo epigenetic CRISPR screen identifies Asf1a as an immunotherapeutic target in Kras-mutant lung adenocarcinoma. , 2019, Cancer discovery.
[22] Gregory Riely,et al. Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review. , 2019, JAMA.
[23] Meijin Huang,et al. eIF6 Promotes Colorectal Cancer Proliferation and Invasion by Regulating AKT-Related Signaling Pathways. , 2019, Journal of biomedical nanotechnology.
[24] Bradley P. Coe,et al. Integrative Genomic Analyses Identifies GGA2 as a Cooperative Driver of EGFR‐Mediated Lung Tumorigenesis , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[25] Guanming Lu,et al. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis , 2018, Journal of experimental & clinical cancer research : CR.
[26] N. Sonenberg,et al. Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma , 2018, Nature Medicine.
[27] G. J. Yoshida. Emerging roles of Myc in stem cell biology and novel tumor therapies , 2018, Journal of experimental & clinical cancer research : CR.
[28] L. Mutti,et al. Expression and activity of eIF6 trigger Malignant Pleural Mesothelioma growth in vivo , 2015, Oncotarget.
[29] Michael Kahn,et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update , 2015, Nature Reviews Clinical Oncology.
[30] P. Londei,et al. eIF6 over-expression increases the motility and invasiveness of cancer cells by modulating the expression of a critical subset of membrane-bound proteins , 2015, BMC Cancer.
[31] Michael L. Gatza,et al. An integrated genomics approach identifies drivers of proliferation in luminal subtype human breast cancer , 2014, Nature Genetics.
[32] Konstantinos J. Mavrakis,et al. RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer , 2014, Nature.
[33] Y. Fernández,et al. Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1 , 2014, Oncogene.
[34] S. Biffo,et al. Eukaryotic initiation factor 6 mediates a continuum between 60S ribosome biogenesis and translation , 2009, EMBO reports.
[35] S. Biffo,et al. Expression of a highly conserved protein, p27BBP, during the progression of human colorectal cancer. , 2000, Cancer research.
[36] Xiangying Meng,et al. Boosting visible-light hydrogen evolution of covalent-organic frameworks by introducing Ni-based noble metal-free co-catalyst , 2020 .
[37] David M Jablons,et al. Lung Cancer Staging and Prognosis. , 2016, Cancer treatment and research.